nodes	percent_of_prediction	percent_of_DWPC	metapath
Astemizole—ABCB1—Mitomycin—urinary bladder cancer	0.226	0.324	CbGbCtD
Astemizole—CYP3A4—Thiotepa—urinary bladder cancer	0.103	0.147	CbGbCtD
Astemizole—CYP3A5—Etoposide—urinary bladder cancer	0.0713	0.102	CbGbCtD
Astemizole—ABCB1—Gemcitabine—urinary bladder cancer	0.065	0.0932	CbGbCtD
Astemizole—ABCB1—Cisplatin—urinary bladder cancer	0.0472	0.0677	CbGbCtD
Astemizole—ABCB1—Etoposide—urinary bladder cancer	0.0464	0.0666	CbGbCtD
Astemizole—ABCB1—Doxorubicin—urinary bladder cancer	0.0317	0.0454	CbGbCtD
Astemizole—ABCB1—Methotrexate—urinary bladder cancer	0.0307	0.044	CbGbCtD
Astemizole—CYP2D6—Doxorubicin—urinary bladder cancer	0.0298	0.0428	CbGbCtD
Astemizole—CYP3A4—Etoposide—urinary bladder cancer	0.0278	0.0399	CbGbCtD
Astemizole—CYP3A4—Doxorubicin—urinary bladder cancer	0.019	0.0272	CbGbCtD
Astemizole—CYP2J2—prostate gland—urinary bladder cancer	0.00701	0.107	CbGeAlD
Astemizole—CYP3A4—urine—urinary bladder cancer	0.00515	0.0785	CbGeAlD
Astemizole—CYP2D6—urine—urinary bladder cancer	0.00507	0.0773	CbGeAlD
Astemizole—CYP2J2—female reproductive system—urinary bladder cancer	0.00382	0.0583	CbGeAlD
Astemizole—CYP2J2—vagina—urinary bladder cancer	0.00346	0.0527	CbGeAlD
Astemizole—KCNH2—prostate gland—urinary bladder cancer	0.00299	0.0455	CbGeAlD
Astemizole—KCNH2—seminal vesicle—urinary bladder cancer	0.00253	0.0385	CbGeAlD
Astemizole—CYP3A5—prostate gland—urinary bladder cancer	0.00247	0.0376	CbGeAlD
Astemizole—HRH1—prostate gland—urinary bladder cancer	0.00239	0.0365	CbGeAlD
Astemizole—KCNH2—renal system—urinary bladder cancer	0.00204	0.031	CbGeAlD
Astemizole—KCNH2—urethra—urinary bladder cancer	0.002	0.0305	CbGeAlD
Astemizole—HRH1—epithelium—urinary bladder cancer	0.00176	0.0268	CbGeAlD
Astemizole—HRH1—smooth muscle tissue—urinary bladder cancer	0.00169	0.0258	CbGeAlD
Astemizole—CYP3A5—renal system—urinary bladder cancer	0.00168	0.0256	CbGeAlD
Astemizole—KCNH2—female reproductive system—urinary bladder cancer	0.00163	0.0248	CbGeAlD
Astemizole—HRH1—urethra—urinary bladder cancer	0.0016	0.0244	CbGeAlD
Astemizole—KCNH2—vagina—urinary bladder cancer	0.00147	0.0225	CbGeAlD
Astemizole—ABCB1—prostate gland—urinary bladder cancer	0.00131	0.02	CbGeAlD
Astemizole—HRH1—female reproductive system—urinary bladder cancer	0.00131	0.0199	CbGeAlD
Astemizole—CYP3A4—renal system—urinary bladder cancer	0.00126	0.0192	CbGeAlD
Astemizole—CYP2D6—renal system—urinary bladder cancer	0.00124	0.0189	CbGeAlD
Astemizole—CYP3A5—vagina—urinary bladder cancer	0.00122	0.0185	CbGeAlD
Astemizole—HRH1—vagina—urinary bladder cancer	0.00118	0.018	CbGeAlD
Astemizole—ABCB1—seminal vesicle—urinary bladder cancer	0.00111	0.0169	CbGeAlD
Astemizole—CYP3A4—female reproductive system—urinary bladder cancer	0.00101	0.0154	CbGeAlD
Astemizole—CYP2D6—female reproductive system—urinary bladder cancer	0.000994	0.0151	CbGeAlD
Astemizole—ABCB1—epithelium—urinary bladder cancer	0.000963	0.0147	CbGeAlD
Astemizole—KCNH2—lymph node—urinary bladder cancer	0.000954	0.0145	CbGeAlD
Astemizole—ABCB1—renal system—urinary bladder cancer	0.000893	0.0136	CbGeAlD
Astemizole—ABCB1—urethra—urinary bladder cancer	0.000877	0.0134	CbGeAlD
Astemizole—HRH1—lymph node—urinary bladder cancer	0.000764	0.0116	CbGeAlD
Astemizole—ABCB1—female reproductive system—urinary bladder cancer	0.000715	0.0109	CbGeAlD
Astemizole—ABCB1—vagina—urinary bladder cancer	0.000647	0.00985	CbGeAlD
Astemizole—ABCB1—lymph node—urinary bladder cancer	0.000418	0.00637	CbGeAlD
Astemizole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000273	0.00115	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—NAT2—urinary bladder cancer	0.000269	0.00114	CbGpPWpGaD
Astemizole—CYP2D6—Biological oxidations—HPGDS—urinary bladder cancer	0.000258	0.00109	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.000252	0.00106	CbGpPWpGaD
Astemizole—KCNH2—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.000252	0.00106	CbGpPWpGaD
Astemizole—ABCB1—HIF-1-alpha transcription factor network—CREBBP—urinary bladder cancer	0.000251	0.00106	CbGpPWpGaD
Astemizole—CYP2D6—Biological oxidations—GSTT1—urinary bladder cancer	0.00025	0.00106	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.00025	0.00106	CbGpPWpGaD
Astemizole—CYP3A5—Biological oxidations—GSTP1—urinary bladder cancer	0.000244	0.00103	CbGpPWpGaD
Astemizole—CYP3A5—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000241	0.00101	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—RRM2—urinary bladder cancer	0.000233	0.00098	CbGpPWpGaD
Astemizole—ABCB1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000228	0.000963	CbGpPWpGaD
Astemizole—CYP3A5—Biological oxidations—GSTM1—urinary bladder cancer	0.000224	0.000945	CbGpPWpGaD
Astemizole—CYP3A5—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000221	0.000932	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—HPGDS—urinary bladder cancer	0.000215	0.000908	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—ENO2—urinary bladder cancer	0.000215	0.000908	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000214	0.000903	CbGpPWpGaD
Astemizole—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000211	0.00089	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—GSTT1—urinary bladder cancer	0.000209	0.000881	CbGpPWpGaD
Astemizole—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000208	0.000878	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—GSTZ1—urinary bladder cancer	0.000207	0.000872	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.000206	0.000867	CbGpPWpGaD
Astemizole—KCNH2—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.000204	0.000861	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000202	0.00085	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—GSTO2—urinary bladder cancer	0.000196	0.000827	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—NAT1—urinary bladder cancer	0.000196	0.000827	CbGpPWpGaD
Astemizole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	0.000189	0.000796	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—UGT2B7—urinary bladder cancer	0.000179	0.000756	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—NQO1—urinary bladder cancer	0.000174	0.000732	CbGpPWpGaD
Astemizole—CYP2D6—Biological oxidations—GSTP1—urinary bladder cancer	0.000173	0.000732	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—CXCL8—urinary bladder cancer	0.000172	0.000727	CbGpPWpGaD
Astemizole—CYP2D6—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000171	0.000722	CbGpPWpGaD
Astemizole—ABCB1—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	0.000171	0.00072	CbGpPWpGaD
Astemizole—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000169	0.000711	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000168	0.00071	CbGpPWpGaD
Astemizole—ABCB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000165	0.000696	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—IL2—urinary bladder cancer	0.000165	0.000695	CbGpPWpGaD
Astemizole—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000164	0.00069	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—CYP4B1—urinary bladder cancer	0.000161	0.000681	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.00016	0.000676	CbGpPWpGaD
Astemizole—CYP2D6—Biological oxidations—GSTM1—urinary bladder cancer	0.000159	0.000672	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	0.000157	0.000664	CbGpPWpGaD
Astemizole—CYP2D6—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000157	0.000663	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—SLC19A1—urinary bladder cancer	0.000152	0.000643	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—GSTZ1—urinary bladder cancer	0.000149	0.00063	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—PRSS3—urinary bladder cancer	0.000149	0.000626	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.000147	0.000619	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—GSTP1—urinary bladder cancer	0.000145	0.00061	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—GSTO2—urinary bladder cancer	0.000142	0.000597	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—NAT1—urinary bladder cancer	0.000142	0.000597	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.00014	0.000591	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	0.000139	0.000588	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—TYMS—urinary bladder cancer	0.000135	0.000568	CbGpPWpGaD
Astemizole—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000135	0.000567	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—GSTM1—urinary bladder cancer	0.000133	0.000561	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—NCOR1—urinary bladder cancer	0.000133	0.000561	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—UGT2B7—urinary bladder cancer	0.00013	0.000546	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—GPX1—urinary bladder cancer	0.000127	0.000537	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—ERCC2—urinary bladder cancer	0.000125	0.000527	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	0.000123	0.00052	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	0.000123	0.000518	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	0.000122	0.000515	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	0.00012	0.000506	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—TYMP—urinary bladder cancer	0.000119	0.000501	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—MTHFR—urinary bladder cancer	0.000118	0.000496	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—CYP4B1—urinary bladder cancer	0.000117	0.000492	CbGpPWpGaD
Astemizole—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	0.000113	0.000478	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	0.000113	0.000476	CbGpPWpGaD
Astemizole—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000112	0.000472	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—SLC19A1—urinary bladder cancer	0.00011	0.000465	CbGpPWpGaD
Astemizole—KCNH2—Neuronal System—HRAS—urinary bladder cancer	0.000108	0.000456	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—NAT2—urinary bladder cancer	0.000107	0.000453	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	0.000107	0.000453	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	0.000107	0.000452	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—GSTO2—urinary bladder cancer	0.000107	0.000451	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—NAT1—urinary bladder cancer	0.000107	0.000451	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	0.000106	0.000448	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	0.000106	0.000446	CbGpPWpGaD
Astemizole—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	0.000104	0.00044	CbGpPWpGaD
Astemizole—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000103	0.000434	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—HDAC4—urinary bladder cancer	0.000103	0.000432	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	0.000101	0.000425	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—NAT1—urinary bladder cancer	0.000101	0.000425	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	9.78e-05	0.000412	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—PPARG—urinary bladder cancer	9.53e-05	0.000402	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—RRM2—urinary bladder cancer	9.27e-05	0.000391	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	9.22e-05	0.000389	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—CREBBP—urinary bladder cancer	9.16e-05	0.000386	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	9.09e-05	0.000383	CbGpPWpGaD
Astemizole—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	9.09e-05	0.000383	CbGpPWpGaD
Astemizole—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—urinary bladder cancer	8.97e-05	0.000378	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	8.97e-05	0.000378	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	8.8e-05	0.000371	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	8.77e-05	0.00037	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—GLI1—urinary bladder cancer	8.59e-05	0.000362	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—ENO2—urinary bladder cancer	8.59e-05	0.000362	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—HPGDS—urinary bladder cancer	8.59e-05	0.000362	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—TYMP—urinary bladder cancer	8.58e-05	0.000362	CbGpPWpGaD
Astemizole—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—urinary bladder cancer	8.47e-05	0.000357	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—GSTT1—urinary bladder cancer	8.33e-05	0.000351	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	8.31e-05	0.000351	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	8.3e-05	0.00035	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—PRSS3—urinary bladder cancer	8.1e-05	0.000342	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	7.93e-05	0.000334	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	7.84e-05	0.00033	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—NAT2—urinary bladder cancer	7.76e-05	0.000327	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	7.67e-05	0.000323	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	7.65e-05	0.000323	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	7.64e-05	0.000322	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—PTGS2—urinary bladder cancer	7.5e-05	0.000316	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	7.29e-05	0.000308	CbGpPWpGaD
Astemizole—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—urinary bladder cancer	7.2e-05	0.000304	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	7.09e-05	0.000299	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	6.95e-05	0.000293	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—CXCL8—urinary bladder cancer	6.92e-05	0.000292	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—NQO1—urinary bladder cancer	6.92e-05	0.000292	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—RRM2—urinary bladder cancer	6.7e-05	0.000283	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	6.59e-05	0.000278	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—NAT1—urinary bladder cancer	6.59e-05	0.000278	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—PTEN—urinary bladder cancer	6.54e-05	0.000276	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—TYMP—urinary bladder cancer	6.48e-05	0.000273	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	6.36e-05	0.000268	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—EP300—urinary bladder cancer	6.24e-05	0.000263	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	6.22e-05	0.000262	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—ENO2—urinary bladder cancer	6.21e-05	0.000262	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	6.21e-05	0.000262	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—TYMP—urinary bladder cancer	6.1e-05	0.000257	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	6.02e-05	0.000254	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	6.02e-05	0.000254	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	5.92e-05	0.00025	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—RBX1—urinary bladder cancer	5.89e-05	0.000248	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	5.87e-05	0.000248	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—NAT2—urinary bladder cancer	5.86e-05	0.000247	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	5.77e-05	0.000243	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—TSC1—urinary bladder cancer	5.54e-05	0.000233	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—NAT2—urinary bladder cancer	5.52e-05	0.000233	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	5.42e-05	0.000229	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—TYMS—urinary bladder cancer	5.37e-05	0.000226	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	5.3e-05	0.000224	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	5.3e-05	0.000224	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—JAG1—urinary bladder cancer	5.27e-05	0.000222	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	5.22e-05	0.00022	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	5.12e-05	0.000216	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—GPX1—urinary bladder cancer	5.08e-05	0.000214	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—RRM2—urinary bladder cancer	5.06e-05	0.000213	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—NQO1—urinary bladder cancer	5e-05	0.000211	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	4.99e-05	0.000211	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	4.99e-05	0.00021	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—RRM2—urinary bladder cancer	4.77e-05	0.000201	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	4.69e-05	0.000198	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—ENO2—urinary bladder cancer	4.68e-05	0.000197	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—HPGDS—urinary bladder cancer	4.68e-05	0.000197	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—GSTT1—urinary bladder cancer	4.54e-05	0.000192	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—RHOA—urinary bladder cancer	4.46e-05	0.000188	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—ENO2—urinary bladder cancer	4.41e-05	0.000186	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	4.41e-05	0.000186	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	4.28e-05	0.000181	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—S100B—urinary bladder cancer	4.27e-05	0.00018	CbGpPWpGaD
Astemizole—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.25e-05	0.000179	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	4.17e-05	0.000176	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—RHOA—urinary bladder cancer	4.05e-05	0.000171	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—TYMP—urinary bladder cancer	3.99e-05	0.000168	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—CXCL8—urinary bladder cancer	3.91e-05	0.000165	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—TYMS—urinary bladder cancer	3.88e-05	0.000164	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—NCOR1—urinary bladder cancer	3.84e-05	0.000162	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	3.83e-05	0.000162	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	3.83e-05	0.000162	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—PPARG—urinary bladder cancer	3.8e-05	0.00016	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—NQO1—urinary bladder cancer	3.78e-05	0.000159	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—IL2—urinary bladder cancer	3.74e-05	0.000158	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—GPX1—urinary bladder cancer	3.67e-05	0.000155	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	3.65e-05	0.000154	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—NAT2—urinary bladder cancer	3.61e-05	0.000152	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	3.61e-05	0.000152	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—NQO1—urinary bladder cancer	3.56e-05	0.00015	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—CXCL8—urinary bladder cancer	3.55e-05	0.00015	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—IL2—urinary bladder cancer	3.39e-05	0.000143	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	3.39e-05	0.000143	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—TERT—urinary bladder cancer	3.38e-05	0.000143	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—GSTP1—urinary bladder cancer	3.15e-05	0.000133	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—RRM2—urinary bladder cancer	3.12e-05	0.000131	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—FGFR3—urinary bladder cancer	3.1e-05	0.000131	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—ESR1—urinary bladder cancer	3.01e-05	0.000127	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	2.99e-05	0.000126	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	2.97e-05	0.000125	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—TYMS—urinary bladder cancer	2.93e-05	0.000123	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—NCOR1—urinary bladder cancer	2.89e-05	0.000122	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—GSTM1—urinary bladder cancer	2.89e-05	0.000122	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.89e-05	0.000122	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.89e-05	0.000122	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.8e-05	0.000118	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—GPX1—urinary bladder cancer	2.77e-05	0.000117	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—TYMS—urinary bladder cancer	2.76e-05	0.000116	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—PPARG—urinary bladder cancer	2.75e-05	0.000116	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	2.73e-05	0.000115	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	2.73e-05	0.000115	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—ERCC2—urinary bladder cancer	2.72e-05	0.000115	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CREBBP—urinary bladder cancer	2.64e-05	0.000111	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	2.64e-05	0.000111	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—GPX1—urinary bladder cancer	2.61e-05	0.00011	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—IGF1—urinary bladder cancer	2.61e-05	0.00011	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—PTEN—urinary bladder cancer	2.61e-05	0.00011	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—EGFR—urinary bladder cancer	2.6e-05	0.000109	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	2.56e-05	0.000108	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—MTHFR—urinary bladder cancer	2.56e-05	0.000108	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—EP300—urinary bladder cancer	2.49e-05	0.000105	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—KRAS—urinary bladder cancer	2.45e-05	0.000103	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	2.41e-05	0.000102	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—RHOA—urinary bladder cancer	2.39e-05	0.000101	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—NQO1—urinary bladder cancer	2.33e-05	9.81e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—ERBB2—urinary bladder cancer	2.21e-05	9.33e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	2.16e-05	9.12e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CXCL8—urinary bladder cancer	2.1e-05	8.85e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—HRAS—urinary bladder cancer	2.08e-05	8.79e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—PPARG—urinary bladder cancer	2.07e-05	8.74e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—IL2—urinary bladder cancer	2.01e-05	8.46e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CREBBP—urinary bladder cancer	1.99e-05	8.4e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CCND1—urinary bladder cancer	1.95e-05	8.24e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—PPARG—urinary bladder cancer	1.95e-05	8.24e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.94e-05	8.18e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—MMP9—urinary bladder cancer	1.9e-05	8e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CDKN1A—urinary bladder cancer	1.89e-05	7.97e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PTEN—urinary bladder cancer	1.89e-05	7.96e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—PTEN—urinary bladder cancer	1.89e-05	7.95e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	1.88e-05	7.92e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.8e-05	7.6e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—EP300—urinary bladder cancer	1.8e-05	7.59e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—EP300—urinary bladder cancer	1.8e-05	7.58e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.78e-05	7.52e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.78e-05	7.52e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—SRC—urinary bladder cancer	1.75e-05	7.38e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.71e-05	7.2e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.68e-05	7.07e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—PTGS2—urinary bladder cancer	1.63e-05	6.88e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.58e-05	6.64e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—MYC—urinary bladder cancer	1.57e-05	6.61e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	1.54e-05	6.48e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—EGFR—urinary bladder cancer	1.53e-05	6.47e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—KRAS—urinary bladder cancer	1.45e-05	6.11e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—PTEN—urinary bladder cancer	1.42e-05	6e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—EP300—urinary bladder cancer	1.36e-05	5.72e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—PTEN—urinary bladder cancer	1.34e-05	5.65e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—TP53—urinary bladder cancer	1.29e-05	5.43e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—EP300—urinary bladder cancer	1.28e-05	5.39e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.28e-05	5.39e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—HRAS—urinary bladder cancer	1.23e-05	5.19e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.23e-05	5.18e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	1e-05	4.24e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—PTEN—urinary bladder cancer	8.76e-06	3.7e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—EP300—urinary bladder cancer	8.36e-06	3.52e-05	CbGpPWpGaD
